Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. GOOGL
6. VRTS
7. HPE
8. SPY
9. SNOW
10. AVGO

Go back to Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
(NASDAQ: SPTX) Delayed: 24.91 +1.30 (5.51%)
Previous Close $23.61    52 Week High $ 
Open $23.66    52 Week Low $ 
Day High $25.21    P/E N/A 
Day Low $23.65    EPS $ 
Volume 156,428